Dr. Ing. h.c. F. Porsche AG (P911) Fair Value & Analysis
Consumer Cyclical · DE · Market cap €42.3B
Fair value as of: Jul 12, 2026
From 26 valuation models · updated 26 days ago
Fair value updated Jul 12, 2026, revised from €17.05 to €34.68 (+103.4%) since Jul 5, 2026. Share price −7.9% over the past month.
Below-average quality, and screening another 20% overvalued on our models.
What matters now
- Solid but not exceptional quality (49/100) and above fair value, neither a clear bargain nor a standout compounder.
- Our model range runs from €34.68 (bear) to €43.06 (bull), base €34.68. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 49/100 (below-average quality) with high evidence: the data supports the verdict.
Price vs Fair Value (4 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 12, 2026.
How to read this chart
46‑month range €35.52 – €107.39 · fair‑value band €34.68 – €43.06 · the €43.54 price screens above the €34.68 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 12, 2026.
Analysis
Dr. Ing. h.c. F. Porsche AG (P911) currently trades at €43.54, while our model-based Fair Value estimate is €34.68, implying the stock looks roughly 20.4% overvalued today. We read business quality at 49/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Dr. Ing. h.c. F. Porsche AG generated revenue of €35.8B at a net margin of 0.9%. Revenue declined 5.2% year over year. It earns a return on equity of 0.8%. Net debt stands at €6.4B. Fundamentals as of Jul 12, 2026
Our scenario range runs from €34.68 (bear case) to €43.06 (bull case); at €43.54, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 12% below its 52-week high and 22% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at 25% fair-value upside, at -20%, P911 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models (€75.46) versus Multiples (€9.46). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 12, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 48 · Market factors (momentum, volatility) 55
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Dr. Ing. h.c. F. Porsche AG engages in automotive and financial services business in Germany, Europe, North America, China, and internationally. The company procures, develops, manufactures, and sells vehicles, as well as related services.
Full company description
Dr. Ing. h.c. F. Porsche AG engages in automotive and financial services business in Germany, Europe, North America, China, and internationally. The company procures, develops, manufactures, and sells vehicles, as well as related services. It also offers leasing, dealer and customer financing, mobility services for Porsche brand vehicles, and other finance-related services. The company was formerly known as Porsche Fünfte Vermögensverwaltung AG and changed its name to Dr. Ing. h.c. F. Porsche AG in November 2009. The company was founded in 2009 and is headquartered in Stuttgart, Germany. Dr. Ing. h.c. F. Porsche AG is a subsidiary of Porsche Holding Stuttgart GmbH.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Dr. Ing. h.c. F. Porsche AG reported revenue of €36.3B in FY2025 versus €33.1B in FY2021, a compound +2.3%/yr. Reported net income was €431M in FY2025, compounding −42.8%/yr from FY2021.
P911 screens 20% overvalued. Compare with Toyota Motor Corporation →
Recent news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- From Porsche penthouses to Nobu lofts: Inside the $67 billion boom in luxury branded residences
- Group 1 Automotive Buys Atlanta Lexus, Porsche, and Jaguar Land Rover Dealerships for $1.3 Billion
- Porsche Profit Jumps 34% Despite 5% Revenue Decline
Peer Group
Auto Manufacturers · 119 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Auto Manufacturers median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Auto Manufacturers stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Toyota Motor Corporation TM | $179.76 | $224.63 | +25% |
| BYD Company 81211 | HK$80.55 | HK$50.85 | -37% |
| Hyundai Motor Company 005380 | 425,000 KRW | 616,918 KRW | +45% |
| General Motors Company GM | $77.72 | $56.93 | -27% |
| Bayerische Motoren Werke Aktiengesellschaft BMWM5N | 1,909 MXN | 2,944 MXN | +54% |
| Ferrari N.V RACE | $376.64 | $228.05 | -39% |
| Ford Motor Company F | C$11.86 | C$4.00 | -66% |
| Mercedes-Benz Group BENZ | C$20.44 | C$35.15 | +72% |
| Volkswagen AG VOW | 2,149 CZK | 7,191 CZK | +235% |
| Maruti Suzuki India Limited MARUTI | ₹13,803 | ₹8,236 | -40% |
Compare Dr. Ing. h.c. F. Porsche AG with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is Dr. Ing. h.c. F. Porsche AG (P911) overvalued or undervalued?
What is the fair value of P911?
What is the quality score of P911?
What is the revenue of Dr. Ing. h.c. F. Porsche AG (P911)?
What is the net profit margin of P911?
Does Dr. Ing. h.c. F. Porsche AG pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Dr. Ing. h.c. F. Porsche AG and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.